Teva Pharmaceuticals - Wikipedia
Ex-pharmaceutical company boss faces insider trading charges over Teva deal | The Times of Israel
Teva to Pay $420M to Settle Shareholders' Generic Drug Pricing Lawsuit — Report
Teva Partners with Tikun Olam-Cannbit to Sell Medical Cannabis Products – Report
Israeli professor settles Mobileye insider trading case in U.S. | Reuters
Exclusive: AbbVie in talks to sell $5 billion women's drugs portfolio - sources
EU fines Teva €60.5m for "pay for delay" pact - Globes
Allergan Buying Opportunity According to Golub Group
Berkshire Hathaway Doubles Teva Bet, Confirms Apple Purchases
Page 14 - New York Ltd High Resolution Stock Photography and Images - Alamy
SEC charges two Israeli residents with Mobileye insider trading | Reuters
Two Israelis accused of Mobileye insider trading | The Times of Israel
J&J Eying Surgical Robotics Firm Auris Health: Bloomberg
Page 14 - New York Ltd High Resolution Stock Photography and Images - Alamy
U.S. charges founder of drug company bought by Teva in insider trading case | Nasdaq
Page 14 - New York Ltd High Resolution Stock Photography and Images - Alamy
Goldman Sachs vice-president charged with insider trading in US - Hindustan Times
Business in Brief: Teva patent dispute with Swiss firm reaches U.S. Supreme Court - Business - Haaretz.com
GSK's $235 million verdict revived against Teva, again | Reuters.com
US charges ex-CEO of drug company with fraud tied to Teva tender offer By Reuters
Teva's Multibillion-Dollar Purchase of Allergan Approved
Mayne Pharma Nears Deal for Teva Assets: Source
Teva Pharma shares sink as sales forecast disappoints market
